Business Context and Reporting Period
Company: Inmune Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 26, 2021
Reporting Period: Event date April 26, 2021
The filing reports an "Other Event" (Item 8.01) regarding a scheduled corporate presentation. The Company is an emerging growth company incorporated in Nevada.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metric.
Material Changes
No material changes to financial position or operations are reported in this document. The filing solely announces a scheduled corporate event.
Guidance, Outlook, and Management Commentary
Event Announcement: On April 26, 2021, the Company announced that Raymond J. Tesi, MD, will participate in a fireside chat at the B Riley Neuroscience Conference on Wednesday, April 28, 2021.
Exhibits: A press release dated April 26, 2021, is attached as Exhibit 99.1.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing.
Investor Verification Checklist
- Verify the content of the press release attached as Exhibit 99.1 for details on the fireside chat.
- Confirm the date and time of the B Riley Neuroscience Conference presentation (April 28, 2021).
- Review subsequent filings for any financial updates or strategic announcements made during the conference.